The WHO Safe Childbirth Checklist implementation: impact on the prescription of magnesium sulphate through a one-year longitudinal study

Table 3 Compliance with the prescription protocol for magnesium sulphate in all women and in those with preeclampsia (PE) with severe features before and after implementation of the Safe Childbirth Checklist in a hospital in Rio Grande do Norte, Brazil, in 2016

		TOTAL n = 720	BEFORE n = 360	AFTER n = 360	p-value
Group of women	Compliance	% (number)	% (number)	% (number)
Overall (n = 720)*	Yes	80.0 (576)	74.7 (269)	85.3 (307)	0.001
Overall (n = 720)*	No	20.0 (144)	25.3 (91)	14.7 (53)	0.001
PE with severe features (n = 186)	Yes	25.3 (47)	19.1 (21)	34.2 (26)	0.025
PE with severe features (n = 186)	No	74.7 (139)	80.9 (89)	65.8 (50)	0.025

*“Yes” was recorded for an adequate prescription decision (prescription when needed or no prescription when not needed); “No” was recorded for an inadequate prescription decision (no prescription when needed or prescription when not needed)

ISSN: 1471-2393